Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

cyanide-induced parkinsonism - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

cyanide-induced parkinsonism

MONDO:0017640

Overview

Cyanide-induced parkinsonism is a rare parkinsonian syndrome due to intoxication which develops in individuals surviving an acute cyanide intoxication episode or due to chronic exposure to small cyanide doses. It presents several weeks after acute exposure with progressive typical clinical features of parkinsonism including bradykinesia, rigidity, dystonia, hypomimia, hypokinetic dysarthria, postural instability and retropulsion but no resting or postural tremor. Brain MRI reveals bilateral lesions in the pallidum, posterior putamen, substantia nigra, subthalamic nucleus, temporal and occipital cortex, and cerebellum.

ResearchLimited published research (3 articles)

Diagnosis

Biomarker and diagnostic research for cyanide-induced parkinsonism has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for cyanide-induced parkinsonism.

3 publications have been identified in PubMed for cyanide-induced parkinsonism. Research spans Diagnostic / Biomarker (33%), Basic Science / Preclinical (33%), and Epidemiology / Natural History (33%).

Recent Publications

Marchi E (2026). [PMID: 41746958](https://pubmed.ncbi.nlm.nih.gov/41746958/). *PloS one*. [Epidemiology / Natural History]
Baninameh Z (2025). [PMID: 39912496](https://pubmed.ncbi.nlm.nih.gov/39912496/). *Autophagy*. [Diagnostic / Biomarker]
Bi PY (2024). [PMID: 38555279](https://pubmed.ncbi.nlm.nih.gov/38555279/). *Communications biology*. [Basic Science / Preclinical]

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:306692

GARD

Genetic and Rare Diseases Info Center

GARD:21266

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

cyanide-induced parkinsonism

Overview

Diagnosis

Research Landscape

Recent Publications

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team